MAPT and Alzheimer disease: This mechanism exacerbates pathological processes, including Aβ deposition, tau hyperphosphorylation, synaptic damage, and cognitive decline, thereby contributing to the progression of AD (Pan et al., 2022; Zhao and Xu, 2022).